2,145
Views
12
CrossRef citations to date
0
Altmetric
Articles

Risk prediction of pneumothorax in lung malignancy patients treated with percutaneous microwave ablation: development of nomogram model

, , , , &
Pages 488-497 | Received 21 Dec 2020, Accepted 06 Mar 2021, Published online: 23 Mar 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study. J Med Imaging Radiat Oncol. 2013;57(4):466–474.
  • Mazzone P. Preoperative evaluation of the lung resection candidate. Cleve Clin J Med. 2012;79(5):S17–S22.
  • Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(4):v1–21.
  • Donington J, Ferguson M, Mazzone P, et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012;142(6):1620–1635.
  • Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530–1544.
  • Sofocleous CT, May B, Petre EN, et al. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR Am J Roentgenol. 2011;196(5):W606–12.
  • Hess A, Palussiere J, Goyers JF, et al. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258(2):635–642.
  • Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174(1):57–59.
  • Feng W, Liu W, Li C, et al. Percutaneous microwave coagulation therapy for lung cancer. Zhonghua Zhong Liu Za Zhi. 2002;24(4):388–390.
  • Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol. 2008;15(6):1765–1774.
  • Cheng G, Shi L, Qiang W, et al. The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastases. Int J Hyperthermia. 2018;34(4):486–491.
  • Yoshimatsu R, Yamagami T, Terayama K, et al. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest. 2009;135(4):1002–1009.
  • Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol. 2011;197(4):W576–80.
  • Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241(1):275–283.
  • Yamagami T, Kato T, Hirota T, et al. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol. 2006;17(10):1625–1629.
  • Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol. 2008;31(1):122–130.
  • Nour-Eldin NE, Naguib NN, Saeed AS, et al. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. AJR Am J Roentgenol. 2009;193(1):W43–W48.
  • Zheng A, Wang X, Yang X, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98(1):243–248.
  • Kim MS, Hong HP, Ham SY, et al. Complications after 100 sessions of cone-beam computed tomography-guided lung radiofrequency ablation: a single-center, retrospective experience. Int J Hyperthermia. 2020;37(1):763–771.
  • Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24(24):3967–3972.
  • Nour-Eldin NE, Naguib NN, Tawfik AM, et al. Outcomes of an algorithmic approach to management of pneumothorax complicating thermal ablation of pulmonary neoplasms. J Vasc Interv Radiol. 2011;22(9):1279–1286.
  • Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379–387.
  • Lim W, Ridge CA, Nicholson AG, et al. The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg. 2018;8(7):709–718.
  • Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours. Cardiovasc Intervent Radiol. 2020;43(5):667–683.
  • Wang D, Li B, Bie Z, et al. Synchronous core-needle biopsy and microwave ablation for highly suspicious malignant pulmonary nodule via a coaxial cannula. J Cancer Res Ther. 2019;15(7):1484–1489.
  • Xu S, Guan LJ, Shi BQ, et al. Recurrent hemoptysis after bronchial artery embolization: prediction using a nomogram and artificial neural network model. AJR Am J Roentgenol. 2020;215:1490–1498.
  • Hiraki T, Gobara H, Iguchi T, et al. Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int. 2014;2014:152087.
  • Palussiere J, Lagarde P, Aupérin A, et al. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years’ experience in 87 patients from two centers. Cardiovasc Intervent Radiol. 2015;38(1):160–166.
  • The Definition of Emphysema. Report of a national heart, lung, and blood institute, division of lung diseases workshop. Am Rev Respir Dis. 1985;132(1):182–185.
  • Lee KS, Takaki H, Yarmohammadi H, et al. Pleural puncture that excludes the ablation zone decreases the risk of pneumothorax after percutaneous microwave ablation in porcine lung. J Vasc Interv Radiol. 2015;26(7):1052–1058.
  • Hinshaw JL, Lubner MG, Ziemlewicz TJ, et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation-what should you use and why? Radiographics. 2014;34(5):1344–1362.
  • Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol. 2009;32(3):478–483.
  • Clasen S, Kettenbach J, Kosan B, et al. Delayed development of pneumothorax after pulmonary radiofrequency ablation. Cardiovasc Intervent Radiol. 2009;32(3):484–490.
  • Tajiri N, Hiraki T, Mimura H, et al. Measurement of pleural temperature during radiofrequency ablation of lung tumors to investigate its relationship to occurrence of pneumothorax or pleural effusion. Cardiovasc Intervent Radiol. 2008;31(3):581–586.
  • Vogl TJ, Basten LM, Nour-Eldin NA, et al. Microwave ablation (MWA) of pulmonary neoplasms: clinical performance of high-frequency MWA with spatial energy control versus conventional low-frequency MWA. AJR Am J Roentgenol. 2019;213(6):1388–1396.
  • Cross SS, Harrison RF, Kennedy RL. Introduction to neural networks. Lancet. 1995;346(8982):1075–1079.
  • Baxt WG. Application of artificial neural networks to clinical medicine. Lancet. 1995;346(8983):1135–1138.